PressMay 17, 2022 Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19
PressMay 13, 2022 Field Trip and Nue Life Are Collaborating To Bring Psychedelic Therapy Into the Home
PressMay 12, 2022 Osmind Raises $40M Series B Round Led by DFJ Growth to Expand Platform for Breakthrough Mental Health Research and Treatment
PressMay 11, 2022 MindMed Collaborators Prof. Liechti and Dr. Holze Announce Positive Topline Data from Phase 2 Trial Evaluating LSD in Anxiety Disorders
PressMay 10, 2022 Novamind to Host Bionomics’ PREVAIL Trial for Acute Treatment of Social Anxiety Disorder
PressMay 5, 2022 PharmaTher Announces Grant of U.S. Patent on Formulation and Production Process of Ketamine and Ketamine Analogs
PressMay 4, 2022 Nova Mentis Psilocybin Manufacturer Receives Approved Health Canada Importation Permit
PressMay 3, 2022 COMP360 psilocybin therapy shows potential in exploratory open-label studies for anorexia nervosa and severe treatment-resistant depression
PressMay 2, 2022 Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public Companies
PressApril 29, 2022 Allied Corp Announces Purchase Order Continuing into Monthly Supply Agreement for Brazilian Specialty Cancer Care Hospital
